---
title: "Major Depression - CANMAT Guidelines 2016"
organization: "CANMAT"
year: 2016
version: "2.0"
citation_key: "CANMAT_MDD_2016"
url: "https://www.canmat.org"
---

# Major Depressive Disorder

## First-line Pharmacotherapy

### SSRIs
- Escitalopram
- Sertraline
- Fluoxetine
- Paroxetine
- Citalopram

### SNRIs
- Venlafaxine XR
- Duloxetine

### Others
- Bupropion XR
- Mirtazapine
- Agomelatine

## Second-line Options
- Quetiapine XR (monotherapy)
- TCAs (amitriptyline, nortriptyline)
- MAOIs (phenelzine, tranylcypromine)

## Augmentation Strategies (Inadequate Response)

**First-line augmentation:**
- Aripiprazole
- Quetiapine XR
- Risperidone
- Lithium

**Second-line:**
- Bupropion
- Thyroid hormone (T3)
- Second antidepressant

## Treatment Duration
- Continue for minimum 6-9 months after remission
- Recurrent depression: Consider long-term maintenance
